Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Transfusion is Scopus-indexed (Q2, CiteScore 3.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 0041-1132Verify ISSN ↗1537-2995Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: About US$4,100 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 75 / 151 | 50th | Q2 |
| Immunology and Allergy | 157 / 234 | 33rd | Q3 |
| Immunology | 167 / 243 | 31st | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1958–present, best quartile Q2, CiteScore 3.2.
Transfusion is Q2 in Hematology (rank 75 of 151), Q3 in Immunology and Allergy (rank 157 of 234) and Q3 in Immunology (rank 167 of 243), by CiteScore 2025.
Transfusion is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q2 at the 50th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.710, quartile Q2, with an H-index of 158.
The publisher lists an article processing charge of about US$4,100 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Transfusion is published by John Wiley and Sons Inc. Its print ISSN is 0041-1132 and its online ISSN is 1537-2995.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Transfusion has an h-index of 195 and a 2-year mean of 1.77 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #60 of 148 Scopus journals in Hematology.
Transfusion published 474 papers in 2025; its busiest recent year was 2023 with 841. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from United States (39.8%), Canada (11.5%) and China (8.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.